Skip to main content
INCR
NASDAQ Life Sciences

InterCure Completes Initial Botanico Acquisition, Initiates Strategic Review of U.S. Medical Cannabis Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$0.874
Mkt Cap
$47.791M
52W Low
$0.68
52W High
$1.77
52W Position info
29% above low
Off High info
51% below high
Rel. Volume info
12× avg
Market data snapshot near publication time

INCR sits 29% above its 52-week low of $0.68 on elevated volume (12× avg).

Summary

InterCure announced the initial closing of its Botanico acquisition, issuing approximately $2.16 million in shares, and initiated a strategic review of U.S. medical cannabis opportunities following federal rescheduling.


Key Events · M&A and Partnerships · INCR

  • U.S. Medical Cannabis Strategic Review

    InterCure has initiated a strategic review of potential opportunities within regulated U.S. medical cannabis markets, following the historic federal rescheduling of certain state-licensed medical cannabis from Schedule I to Schedule III.

  • Initial Closing of Botanico Acquisition

    The company completed the first tranche of its acquisition of Botanico Ltd., an Israeli cannabis technology and brand company. This involved the issuance of 2,471,061 ordinary shares, valued at approximately $2.16 million based on the current stock price.

  • Expanded Portfolio and Technology Access

    The Botanico acquisition grants InterCure exclusive rights to award-winning American cannabis genetics, proprietary strains, premium brands, and advanced AI-driven production technologies, including strategic alliances with leading U.S. cannabis operators.

  • German Market Momentum

    InterCure reported its first meaningful revenues from the German medical cannabis market earlier this year and plans multiple product launches in the second half of the year to support growing demand.


Analysis · INCR · Life Sciences

InterCure is making a significant strategic pivot by initiating a review of U.S. medical cannabis opportunities, a move enabled by the recent federal rescheduling of cannabis. This could open access to a massive new market for the company. Concurrently, the initial closing of the Botanico acquisition, valued at approximately $2.16 million through share issuance, strengthens InterCure's product portfolio with exclusive U.S. genetics, brands, and AI-driven technologies, positioning it for international growth despite the dilutive effect on existing shareholders.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1410 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INCR was trading at $0.87 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $47.8M. The 52-week trading range was $0.68 to $1.77. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INCR - Latest Insights

INCR
Sep 08, 2026, 4:13 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.39
Real-time Price: $3.30 info
Change: -$2.09 (-39%) info
Market Cap: $39.032M info
INCR
Aug 27, 2026, 11:38 AM EDT
Filing Type: 6-K/A
Importance Score:
7
Price at Filing: $5.74
Real-time Price: $3.30 info
Change: -$2.45 (-43%) info
Market Cap: $39.032M info
INCR
Aug 26, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.85
Real-time Price: $3.30 info
Change: -$2.55 (-44%) info
Market Cap: $39.032M info
INCR
Aug 24, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.15
Real-time Price: $3.30 info
Change: Reverse Stock Split info
Market Cap: $39.032M info
INCR
Aug 24, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.15
Real-time Price: $3.30 info
Change: Reverse Stock Split info
Market Cap: $39.032M info